Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676)
DAMIANI, Daniela
•
Candoni A.
•
Michelutti A.
altro
Fanin R.
2002
Periodico
BLOOD
Archivio
Diritti
metadata only access